DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Caprihans India Ltd is Rated Hold by MarketsMOJO

marketsmojo.com 25 Aug·25 Aug 2026, 7:54 am

Caprihans India Ltd has received a 'Hold' rating from MarketsMOJO, a prominent financial research platform. This assessment implies that the stock is currently fairly valued and does not present a compelling opportunity for immediate buying or selling.

For investors, this rating suggests that holding onto existing shares may be the most prudent strategy at this moment. It signals that while the company is likely stable, there is no immediate catalyst expected to drive significant price growth or a sharp decline in the near term.

Investors should monitor the company's quarterly results and any upcoming sector-specific news. Keeping an eye on broader market trends will also help in deciding whether to maintain the current position or adjust the portfolio later.